Andreas Argyrides
Stock Analyst at Oppenheimer
(5)
Main Sectors:
Top Industries:
33 Stocks
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MNPR Monopar Therapeutics | Maintains: Outperform | 77 115 | 99.39 | 15.71% | 2 | Oct 2, 2025 | |
LRMR Larimar Therapeutics | Maintains: Outperform | 26 21 | 4.87 | 331.21% | 2 | Oct 2, 2025 | |
BNTC Benitec Biopharma | Maintains: Outperform | 35 29 | 13.84 | 109.54% | 2 | Sep 16, 2025 | |
KALA Kala Bio | Maintains: Outperform | 15 33 | 1.54 | 2042.86% | 2 | Sep 11, 2025 | |
SVRA Savara | Maintains: Outperform | 6 8 | 3.49 | 129.23% | 1 | Sep 8, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 510 575 | 453.07 | 26.91% | 1 | Sep 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 12 15 | 5.76 | 160.42% | 2 | Sep 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 19 20 | 5.41 | 269.69% | 2 | Aug 15, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 34 13 | 13.06 | -0.46% | 2 | Aug 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 61 | 27.28 | 123.61% | 1 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 15 7 | 5.8 | 20.69% | 5 | Jun 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 3 | 1.58 | 89.87% | 2 | May 29, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 13 | 22.43 | -42.04% | 7 | May 19, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 4 | 0.51 | 684.31% | 5 | May 16, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 155 90 | 46.22 | 94.72% | 1 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 9 | 2.45 | 267.35% | 1 | May 13, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 47 15 | 15.94 | -5.9% | 8 | Jan 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 181 181 | 204.05 | -11.3% | 9 | Nov 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 7 7 | n/a | n/a | 1 | Aug 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 104 | 8.43 | 1133.69% | 14 | Jun 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 75 | 4.37 | 1616.25% | 1 | Jun 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | 2.57 | 250.19% | 7 | Jun 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 19 19 | 10.31 | 84.29% | 9 | Mar 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 29 29 | 17.57 | 65.05% | 3 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 21 21 | 10.43 | 101.34% | 4 | Feb 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 224 224 | 22.64 | 889.4% | 4 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 57 57 | 24.84 | 129.47% | 2 | Feb 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 6 | Nov 16, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 7 | 0.98 | 614.29% | 3 | Oct 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 10 | 0.68 | 1370.59% | 4 | Aug 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 73 70 | 55.43 | 26.29% | 6 | Aug 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 53 42 | n/a | n/a | 2 | Jan 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Aug 8, 2022 |